F. Vikhanskaya et al., INACTIVATION OF P53 IN A HUMAN OVARIAN-CANCER CELL-LINE INCREASES THESENSITIVITY TO PACLITAXEL BY INDUCING G2 M ARREST AND APOPTOSIS/, Experimental cell research, 241(1), 1998, pp. 96-101
Paclitaxel-induced cytotoxicity, cell cycle perdurbation, and apoptosi
s were determined in a human ovarian cancer cell Line expressing wt p5
3 (A2780) and in a subclone (A2780/E6) obtained upon transfection with
the product of the E6 gene of the human papilloma virus HPV16. The in
activation of wt p53 in A2780/E6 was verified by measuring the inabili
ty of the clone to induce p53 and p21 expression after paclitaxel trea
tment. The p53-negative clone (A2780/E6) was approximately 50-fold mor
e sensitive to paclitaxel than wt p53-expressing A2780 cells. This inc
reased sensitivity was related to the ability of paclitaxel to induce
a strong arrest of cells in the G2/M phase of the cell cycle in A2780/
E6 but not in A2780 cells. This different cell cycle arrest was accomp
anied by increased frequency of paclitaxel-induced p53-independent apo
ptosis, Initial studies on proteases activation tend to exclude a dire
ct role of ICE: and CPP32 in the induction of apoptosis in these cells
and show a paclitaxel-dependent increase in FLICE levels, whose biolo
gical relevance is however at present not defined. (C) 1998 Academic P
ress.